rs2041139

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000537784.5(CACNA2D4):​n.*1967G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0265 in 152,280 control chromosomes in the GnomAD database, including 109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 109 hom., cov: 34)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CACNA2D4
ENST00000537784.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.96

Publications

4 publications found
Variant links:
Genes affected
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
CACNA2D4 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal cone dystrophy 4
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-1792295-C-T is Benign according to our data. Variant chr12-1792295-C-T is described in ClinVar as Benign. ClinVar VariationId is 307805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0724 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D4NM_172364.5 linkc.*1360G>A 3_prime_UTR_variant Exon 38 of 38 ENST00000382722.10 NP_758952.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D4ENST00000537784.5 linkn.*1967G>A non_coding_transcript_exon_variant Exon 15 of 15 1 ENSP00000440231.2
CACNA2D4ENST00000382722.10 linkc.*1360G>A 3_prime_UTR_variant Exon 38 of 38 1 NM_172364.5 ENSP00000372169.4
CACNA2D4ENST00000537784.5 linkn.*1967G>A 3_prime_UTR_variant Exon 15 of 15 1 ENSP00000440231.2
CACNA2D4ENST00000280663.12 linkn.5604G>A non_coding_transcript_exon_variant Exon 36 of 36 2

Frequencies

GnomAD3 genomes
AF:
0.0264
AC:
4021
AN:
152162
Hom.:
109
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0494
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0173
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.0783
Gnomad SAS
AF:
0.0441
Gnomad FIN
AF:
0.0739
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00384
Gnomad OTH
AF:
0.0201
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
12
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
6
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
6
GnomAD4 genome
AF:
0.0265
AC:
4043
AN:
152280
Hom.:
109
Cov.:
34
AF XY:
0.0298
AC XY:
2219
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0497
AC:
2063
AN:
41550
American (AMR)
AF:
0.0174
AC:
266
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.0786
AC:
408
AN:
5188
South Asian (SAS)
AF:
0.0437
AC:
211
AN:
4826
European-Finnish (FIN)
AF:
0.0739
AC:
784
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00384
AC:
261
AN:
68020
Other (OTH)
AF:
0.0227
AC:
48
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
196
393
589
786
982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00885
Hom.:
33
Bravo
AF:
0.0238
Asia WGS
AF:
0.0890
AC:
307
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinal cone dystrophy 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.40
DANN
Benign
0.63
PhyloP100
-3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2041139; hg19: chr12-1901461; API